Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test holds promise for early liver cancer detection

NCT ID NCT02908048

First seen May 07, 2026 · Last updated May 09, 2026 · Updated 1 time

Summary

This study looked at whether tiny bits of genetic material (extracellular RNA) found in the blood can help doctors diagnose liver cancer or other liver diseases. Researchers planned to enroll about 1,865 people with liver cancer, bile duct cancer, cirrhosis, or chronic liver disease. The goal was to see if these blood markers could also predict how well a patient responds to treatment or if cancer comes back after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Mayo Clinic Florida

    Jacksonville, Florida, 32224, United States

  • McGuire VA Medical Center

    Richmond, Virginia, 23249, United States

  • The University of Chicago Medical Center

    Chicago, Illinois, 60637, United States

Conditions

Explore the condition pages connected to this study.